SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-002529
Filing Date
2018-04-04
Accepted
2018-04-04 17:16:15
Documents
5
Period of Report
2018-05-16
Effectiveness Date
2018-04-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235130zdef14a.htm DEF 14A 838196
2 G88562BII001.GIF g88562bii001.gif GRAPHIC 84291
3 G88562BII002.GIF g88562bii002.gif GRAPHIC 37814
4 G155803.JPG g155803.jpg GRAPHIC 11335
5 G257780.JPG g257780.jpg GRAPHIC 5881
  Complete submission text file 0001047469-18-002529.txt   1031576
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-29889 | Film No.: 18738139
SIC: 2834 Pharmaceutical Preparations